RxDoctor Payments Data

Leah Ruhland, OD

Optometrist · Plymouth, MNNPI 1457840191

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,065 of the $1,742 with a category attached, or 61.1%. Johnson & Johnson Vision Care, Inc. accounts for 68.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $1,252 and has fallen 84.7% since, to $192 in 2025. Among optometrist clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,742in general payments, 2019–2025

Across 23 payments — averaging $75.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$1K
  • Alcon$204
  • Coopervision Inc.$106
  • Novartis$105
  • Tarsus Pharmaceuticals, Inc.$76
  • Carl Zeiss Meditec AG$39
  • plus $14 from 1 others

What the payments were for

  • Consulting fees$1,06561%
  • Food & beverage$63837%
  • Gifts$392%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,742 in reported general payments places this provider in the 90th percentile of 826 optometrist providers in Minnesota.

See all optometrist providers in Minnesota →

Medicare billing

Part B allowed, 2024
$5,839
Medicare patients
38
Services billed
1,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost63$866
Timolol Maleate13$78

Paid to pharmacies, not to this prescriber.

Other optometrist in Plymouth

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →